TETRAZOLE DERIVATIVES AND METHODS OF TREATMENT OF METABOLIC-RELATED DISORDERS THEREOF

The present invention relates to certain tetrazole derivatives of Formula (I), and pharmaceutically acceptable salts thereof, which exhibit useful pharmacological properties, for example, as agonists for the RUP25 receptor. Also provided by the present invention are pharmaceutical compositions conta...

Full description

Saved in:
Bibliographic Details
Main Authors SKINNER PHILIP J, RAGHAVAN SUBHAREKHA, LIANG RUI, JUNG JAE-KYU, SCHMIDT DARBY, COLLETTI STEVEN L, TATA JAMES R, IMBRIGLIO JASON E, GHARBAOUI TAWFIK, SCHRADER THOMAS, SEMPLE GRAEME
Format Patent
LanguageEnglish
Slovenian
Published 31.10.2006
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to certain tetrazole derivatives of Formula (I), and pharmaceutically acceptable salts thereof, which exhibit useful pharmacological properties, for example, as agonists for the RUP25 receptor. Also provided by the present invention are pharmaceutical compositions containing compounds of the invention, and methods of using the compounds and compositions of the invention in the treatment of metabolic-related disorders, including dyslipidemia, atherosclerosis, coronary heart disease, insulin resistance, type 2 diabetes, Syndrome-X and the like. In addition, the present invention also provides for the use of the compounds of the invention in combination with other active agents such as those belonging to the class of ±-glucosidase inhibitors, aldose reductase inhibitors, biguanides, HMG-CoA reductase inhibitors, squalene synthesis inhibitors, fibrates, LDL catabolism enhancers, angiotensin converting enzyme (ACE) inhibitors, insulin secretion enhancers and the like.
Bibliography:Application Number: SI20040030058T